Joel Linden, PhD
Joel Linden, PhD
University of Virginia School of Medicine
確認したメール アドレス: - ホームページ
International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors
BB Fredholm, AP IJzerman, KA Jacobson, KN Klotz, J Linden
Pharmacological reviews 53 (4), 527-552, 2001
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
S Deaglio, KM Dwyer, W Gao, D Friedman, A Usheva, A Erat, JF Chen, ...
Journal of Experimental Medicine 204 (6), 1257-1265, 2007
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors—an update
BB Fredholm, AP IJzerman, KA Jacobson, J Linden, CE Müller
Pharmacological reviews 63 (1), 1-34, 2011
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
G Haskó, J Linden, B Cronstein, P Pacher
Nature reviews Drug discovery 7 (9), 759-770, 2008
The cardiac effects of adenosine
L Belardinelli, J Linden, RM Berne
Progress in cardiovascular diseases 32 (1), 73-97, 1989
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection
J Linden
Annual review of pharmacology and toxicology 41 (1), 775-787, 2001
Molecular cloning and characterization of the human A3 adenosine receptor
CA Salvatore, MA Jacobson, HE Taylor, J Linden, RG Johnson
Proceedings of the National Academy of Sciences 90 (21), 10365-10369, 1993
Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions
J Linden
Trends in pharmacological sciences 15 (8), 298-306, 1994
A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells
PE Zarek, CT Huang, ER Lutz, J Kowalski, MR Horton, J Linden, ...
Blood 111 (1), 251-259, 2008
Purinergic regulation of the immune system
C Cekic, J Linden
Nature Reviews Immunology 16 (3), 177, 2016
Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system
DL Rosin, A Robeva, RL Woodard, PG Guyenet, J Linden
Journal of Comparative Neurology 401 (2), 163-186, 1998
A2A adenosine receptor induction inhibits IFN-γ production in murine CD4+ T cells
CM Lappas, JM Rieger, J Linden
The Journal of Immunology 174 (2), 1073-1080, 2005
The role of inflammation in vascular diseases
GW Sullivan, IJ Sarembock, J Linden
Journal of Leukocyte Biology 67 (5), 591-602, 2000
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.
J Linden, HE Taylor, AS Robeva, AL Tucker, JH Stehle, SA Rivkees, ...
Molecular pharmacology 44 (3), 524-532, 1993
Adenosine in tissue protection and tissue regeneration
J Linden
Molecular pharmacology 67 (5), 1385-1387, 2005
Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation
CM Lappas, YJ Day, MA Marshall, VH Engelhard, J Linden
The Journal of experimental medicine 203 (12), 2639-2648, 2006
Structure and function of A1 adenosine receptors1
J Linden
The FASEB journal 5 (12), 2668-2676, 1991
Characterization of human A2B adenosine receptors: Radioligand binding, western blotting, and coupling to Gqin human embryonic kidney 293 cells and HMC-1 mast cells
J Linden, T Thai, H Figler, X Jin, AS Robeva
Molecular Pharmacology 56 (4), 705-713, 1999
Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum
BD Hettinger, A Lee, J Linden, DL Rosin
Journal of Comparative Neurology 431 (3), 331-346, 2001
Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation.
X Jin, RK Shepherd, BR Duling, J Linden
The Journal of clinical investigation 100 (11), 2849-2857, 1997
論文 1–20